N-Formyl-Met-Leu-Phe-Lys
CAS No. 67247-11-4
N-Formyl-Met-Leu-Phe-Lys( fMLFK )
Catalog No. M22300 CAS No. 67247-11-4
N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 102 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 245 | In Stock |
|
| 50MG | 339 | In Stock |
|
| 100MG | 457 | In Stock |
|
| 200MG | 616 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Formyl-Met-Leu-Phe-Lys
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.
-
DescriptionN-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.Chemotactic peptide (fMLFK) binds specifically to receptors on leukocyte membranes. Uptake of chemotactic peptides can contribute to quantitative assessment of neutrophils in localized inflammatory processes and is independent of associated edema formation or microcirculatory compromise.
-
In Vitro——
-
In Vivo——
-
SynonymsfMLFK
-
PathwayOthers
-
TargetOther Targets
-
RecptorFPR1|FPR2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67247-11-4
-
Formula Weight565.73
-
Molecular FormulaC27H43N5O6S
-
Purity>98% (HPLC)
-
SolubilityH2O
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.He HQ, et al. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306.
molnova catalog
related products
-
N-Methyl-N-(trimethy...
Used as organic synthesis and medicine intermediate.
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.
-
[Pro9] Substance P
[Pro9]-Substance P is a potent, reversible and selective agonist of NK-1 tachykinin receptors with an EC50 of 0.93 nM.
Cart
sales@molnova.com